GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
| 
                               
                            
                                
                                                                Synonyms: ER-306323 | ER306323 | Orserdu® | RAD-1901 | RAD1901
                                 
                                                         
                            
                            
                            
                                 
                                
                                elacestrant is an approved drug (FDA & EMA (2023)) 
                                                        
                                                    
                                Compound class: 
                                                            Synthetic organic
                                 
                                
                                    
                                        Comment: Elacestrant is an orally bioactive, selective, non-steroidal dual estrogen receptor degrader (SERD)/selective estrogen receptor modulator (SERM; with antagonist action) [6]. It was developed primarily for antineoplastic potential (via its SERD action at high concentrations) [3]. It has also demonstrated potential to treat the vasomotor symptoms of the menopause with estrogen-like effects detected at low concentrations (SERM activity), but the pharmacology in this setting is very complex [4]. Elacestrant crosses the blood-brain barrier, so is predicted to provide efficacy against breast cancer metastases in the brain.
                                    
                                 
                            
                            
                          
                                
                                    
                                
                          
                                   
                                   
                                  
                                      
                                     
                                   
                                   
                                    
                                    
                                     | 
                                    
                                        
                                         
  | 
                                    
                                
                                |||||||||||||||||||||||||||||||||||
Classification ![]()  | 
                                                    |
| Compound class | Synthetic organic | 
| Approved drug? | Yes. EU EMA (2023) | US FDA (2023) | 
IUPAC Name ![]()  | 
                                                        
| (6R)-6-[2-[ethyl-[[4-[2-(ethylamino)ethyl]phenyl]methyl]amino]-4-methoxyphenyl]-5,6,7,8-tetrahydronaphthalen-2-ol | 
International Nonproprietary Names ![]()  | 
                                                        |
| INN number | INN | 
| 10247 | elacestrant | 
Synonyms ![]()  | 
                                                        
| ER-306323 | ER306323 | Orserdu® | RAD-1901 | RAD1901 | 
Database Links ![]()  | 
                                                        |
| BindingDB Ligand | 349630 | 
| CAS Registry No. | 722533-56-4 (source: WHO INN record) | 
| ChEMBL Ligand | CHEMBL4297509 | 
| DrugBank Ligand | DB06374 | 
| GtoPdb PubChem SID | 479821130 | 
| PubChem CID | 23642301 | 
| RCSB PDB Ligand | I0V | 
| Search Google for chemical match using the InChIKey | SIFNOOUKXBRGGB-AREMUKBSSA-N | 
| Search Google for chemicals with the same backbone | SIFNOOUKXBRGGB | 
| Search PubMed clinical trials | elacestrant | 
| Search PubMed titles | elacestrant | 
| Search PubMed titles/abstracts | elacestrant | 
| UniChem Compound Search for chemical match using the InChIKey | SIFNOOUKXBRGGB-AREMUKBSSA-N | 
| UniChem Connectivity Search for chemical match using the InChIKey | SIFNOOUKXBRGGB-AREMUKBSSA-N | 
Product supplier links are provided as a service to assist in identifying commercial suppliers of reagents that are mentioned on the IUPHAR/BPS Guide to PHARMACOLOGY database website, and do not imply their endorsement by NC-IUPHAR.
Links are provided in return for sponsorship, used to fund improvements to this database. The sponsorship account is managed and audited by the University of Edinburgh, a charitable body registered in Scotland, SC005336. If you are interested in sponsoring the database, please contact us.
✖| 
                                                                     
                                                                         
                                                                         
                                                                             
                                                                         
                                                                         
                                                                           
                                                                           Elacestrant (links to external site) 
                                                                    
                                                                Cat. No. HY-19822  |